Axon shares rally on blowout Q1 earnings and raised full-year guidance. Both Wall Street and derivatives market suggests significant further upside in AXON stock from here.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Axon shares rally on blowout Q1 earnings and raised full-year guidance. Both Wall Street and derivatives market suggests significant further upside in AXON stock from here.
Shares of The Trade Desk (NASDAQ:TTD) are down roughly 13% to $20.41 in early Friday trading after the company posted a Q1 2026 earnings miss and issued a softer Q2 2026 outlook than the Street had hoped to see. The stock closed Thursday at $23.49, already down 38% year to date (YTD) heading into the ... Trade Desk Tumbles 13%, AppLovin Holds Gains as Ad-Tech Q1 Earnings Split Wall Street
Shares of Axon Enterprise rose sharply Thursday after the maker of law-enforcement technology like Tasers and body cameras reported a spike in international sales. Axon stock jumped 7.6% to $415.14 on Thursday.
AppLovin (APP) retains a significant moat in mobile gaming advertising and expanding into consumer a
Axon Enterprise's (AXON) Q1 performance, specifically in bookings, strengthens its case for durable
Axon raises its 2026 revenue outlook after Q1 sales surge 33.7%, fueled by strong demand for TASER 10, body cameras and AI offerings.
Axon Enterprise (NasdaqGS:AXON) reported a very large year-over-year rise in counter-drone bookings, around 500%, with revenue more than tripling. The company highlighted rapid growth in its AI-focused offerings alongside this counter-drone performance. Axon raised its full-year revenue guidance, pointing to stronger-than-previously-expected business momentum. For investors following Axon Enterprise, this update adds a new dimension to a story often centered on Tasers, body cameras, and...
According to the average brokerage recommendation (ABR), one should invest in Axon (AXON). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Our AppLovin (NASDAQ:APP) call comes at a moment when the stock has recovered ground after a weak first quarter. Shares trade at $468.83 as of writing, and our proprietary model points to meaningful upside from here. The 24/7 Wall St. price target for AppLovin is $576.79, implying 23.03% upside over the next 12 months. Confidence ... AppLovin Price Prediction Raised After Q1 Earnings Beat
A beat and a guidance raise mark Axon's ninth straight quarter of 30%-plus growth
Axon Enterprise (NASDAQ:AXON) executives used the company’s first-quarter 2026 earnings call to highlight continued rapid growth, rising adoption of its AI-focused offerings, and accelerating demand for its counter-drone business, while raising full-year revenue guidance. Management frames AI as a
The headline numbers for Axon (AXON) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.